Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · Medico Intercontinental Limite · 9 October 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
Medico Intercontinental Limite
BSE: 539938
BSE: 539938
Services › Services › Commercial Services & Supplies › Trading & Distributors
Medico Intercontinental Limite
StateQ4 FY26 filed
Last close · 9 Oct 2026₹26.00
Market cap₹0.0k cr
TTM P/E · P/B · EV/EBITDA— · 0.81 · 20.5
Medico Intercontinental Limite is a Commercial Services & Supplies company. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.
Exhibit 1: Financial summary, FY22–FY26 (all audited; no estimate years)
| ₹ crore · consolidated | FY22 | FY23 | FY24 | FY25 | FY26 |
|---|---|---|---|---|---|
| Revenue | 74 | 76 | 71 | 96 | 84 |
| EBITDA (ex other income) | 5 | 5 | 6 | 8 | 3 |
| margin % | 6.7 | 6.9 | 8.2 | 8.8 | 3.5 |
| Owners' profit | 3 | 4 | 4 | 5 | (3) |
| EPS, as reported (₹) | 9.54 | 5.61 | 3.95 | 5.06 | 3.20 |
| ROE % · ROCE % | 24.5 · 27.0 | 8.8 · 12.8 | 8.8 · 12.6 | 10.4 · 12.6 | (34.0) · (1.5) |
| Debt / equity (x) | 0.68 | 0.11 | 0.11 | 0.35 | 2.08 |
| Cash from operations | 4 | (10) | 6 | (7) | 17 |
| Capex | (0) | (0) | (1) | (2) | (5) |
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · Medico Intercontinental Limite · 9 October 2026Page 2 of 3
Exhibit 2: Quarterly performance, last 8 quarters
| ₹ crore | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 18 | 37 | 19 | 21 | 21 | 20 | 20 | 22 |
| Profit before tax | 1 | 2 | 2 | 2 | (2) | (4) | (1) | (2) |
| Net profit | 1 | 2 | 1 | 1 | (2) | (5) | (2) | (2) |
| EPS (₹) | 1.08 | 1.63 | 1.17 | 1.17 | (0.68) | (1.65) | (0.22) | (0.65) |
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.
Exhibit 3: Peers — basic industry group, by market cap
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| REDINGTON LIMITED | 30,351 | 17.8 | 2.91 | 14.1 | 12.3 | 15.7 | 15.9 | 2.2 |
| MMTC LIMITED | 8,166 | 18.3 | 3.85 | 17.4 | 18.3 | 21.6 | (83.7) | 18426.5 |
| MSTC LIMITED | 4,696 | 20.0 | 5.20 | 13.9 | 24.2 | 31.8 | (13.9) | 86.5 |
| CREATIVE NEWTECH LIMITED | 1,593 | 24.5 | 4.11 | 18.4 | 18.1 | 21.0 | — | 5.2 |
| Pervasive Commodities Limited | 1,178 | — | 13.10 | — | (0.0) | (0.0) | — | 45.0 |
| The Yamuna Syndicate Ltd | 755 | 8.3 | 0.59 | 190.1 | 4.0 | 0.3 | 4.8 | 6.2 |
| SHIV AUM STEELS LIMITED | 748 | 65.8 | 6.19 | 47.7 | 6.0 | 6.9 | — | 4.9 |
| SHANKARA BUILDPRO LIMITED | 609 | 4.6 | 1.12 | 2.7 | 23.4 | 31.8 | — | 3.3 |
Source: exchange data and filed statements via the screener; multiples at current prices.
Exhibit 4: Where the company sits in its group
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/B | 0.8 | 1.0 | 65 of 150 | 57% |
| ROCE | (11.8) | 2.1 | 162 of 177 | 9% |
| ROE | (34.0) | 2.3 | 154 of 158 | 3% |
| Debt / Equity | 2.1 | 0.1 | 139 of 154 | 10% |
| EBITDA margin | 7.7 | 4.5 | 51 of 137 | 63% |
| Revenue growth | 5.1 | (8.6) | 55 of 135 | 60% |
| Profit growth | (299.8) | 0.6 | 138 of 157 | 12% |
| Market cap | 26 | 22 | 85 of 180 | 53% |
Source: MarketPing peer ranks; a rank is a measurement, not a view.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · Medico Intercontinental Limite · 9 October 2026Page 3 of 3
Exhibit 5: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | 1-day % | 5-day % |
|---|---|---|---|---|
| 7 Oct 2026 · Routine SEBI DP compliance certificate for September 2026 quarter | compliance | minimal | — | — |
| 2 Oct 2026 · Medico Intercontinental 42nd AGM results: all 7 resolutions passed | board shareholder meetings | low | — | — |
| 30 Sept 2026 · Proceedings of 42nd AGM held on September 30, 2026 | board shareholder meetings | low | — | — |
| 30 Sept 2026 · Closure of Trading Window | compliance | minimal | — | — |
| 7 Sept 2026 · 42nd AGM Notice and Annual Report Publication | compliance | minimal | — | — |
| 5 Sept 2026 · 42nd AGM on Sept 30 2026; related party deals worth Rs 185.50 cr for vote | board shareholder meetings | low | — | — |
| 5 Sept 2026 · 42nd AGM Notice and Annual Report 2025-26 filed with BSE | board shareholder meetings | low | — | — |
| 3 Sept 2026 · AGM on 30 Sept 2026 via VC; book closure 24 to 30 Sept | board shareholder meetings | low | — | — |
| 17 Aug 2026 · Newspaper publication of Q1 FY27 unaudited financial results | compliance | minimal | — | — |
| 14 Aug 2026 · Q1 FY27 results: standalone profit up, consolidated in loss | results | high | — | — |
Source: exchange announcements; reaction = close-to-close from the filing's session.
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in